Jafari M, Shahverdian A, Sadigh G, Van Etten R
JMIR Cancer. 2024; 10:e57199.
PMID: 39475848
PMC: 11561440.
DOI: 10.2196/57199.
Henry N, Unger J, Vaidya R, Darke A, Skaar T, Fisch M
Contemp Clin Trials. 2024; 147:107712.
PMID: 39395534
PMC: 11620912.
DOI: 10.1016/j.cct.2024.107712.
Graetz I, Hu X, Kocak M, Krukowski R, Anderson J, Waters T
JAMA Netw Open. 2024; 7(6):e2417873.
PMID: 38935379
PMC: 11211959.
DOI: 10.1001/jamanetworkopen.2024.17873.
Gomaa S, Lopez A, Slamon R, Smith R, Lapitan E, Nightingale G
Support Care Cancer. 2023; 31(12):719.
PMID: 38008817
DOI: 10.1007/s00520-023-08170-y.
Green S, Hall L, French D, Rousseau N, Parbutt C, Walwyn R
Ann Behav Med. 2023; 57(11):988-1000.
PMID: 37494669
PMC: 10578395.
DOI: 10.1093/abm/kaad037.
Investigation of Factors Affecting Adherence to Adjuvant Hormone Therapy in Early-Stage Breast Cancer Patients: A Comprehensive Systematic Review.
Yang S, Park S, Bae S, Ahn S, Jeong J, Park K
J Breast Cancer. 2023; 26(4):309-333.
PMID: 37272247
PMC: 10475712.
DOI: 10.4048/jbc.2023.26.e22.
Predictors of adherence and the role of primary non-adherence in antihormonal treatment of breast cancer.
Dragvoll I, Bofin A, Soiland H, Taraldsen G, Engstrom M
BMC Cancer. 2022; 22(1):1247.
PMID: 36456972
PMC: 9716686.
DOI: 10.1186/s12885-022-10362-4.
Adherence to adjuvant endocrine therapy among White British and ethnic minority breast cancer survivors in the United Kingdom.
McGuinness S, Hughes L, Moss-Morris R, Hunter M, Norton S, Moon Z
Eur J Cancer Care (Engl). 2022; 31(6):e13722.
PMID: 36255032
PMC: 9787781.
DOI: 10.1111/ecc.13722.
Medication Non-Adherence in Rheumatology, Oncology and Cardiology: A Review of the Literature of Risk Factors and Potential Interventions.
Gil-Guillen V, Balsa A, Bernardez B, Valdes Y Llorca C, Marquez-Contreras E, de la Haba-Rodriguez J
Int J Environ Res Public Health. 2022; 19(19).
PMID: 36231341
PMC: 9564665.
DOI: 10.3390/ijerph191912036.
Hot flushes and sweating, sleep problems, joint and muscular discomfort, and physical and mental exhaustion in breast cancer survivors during the first 24 months of tamoxifen therapy: a prospective observational study.
Sung S, Min Y, Park S, Lee S
Front Oncol. 2022; 12:844926.
PMID: 35982968
PMC: 9380584.
DOI: 10.3389/fonc.2022.844926.
Public procurement of antineoplastic agents used for treating breast cancer in Brazil between 2013 and 2019.
Dos Santos R, Pepe V, Osorio-de-Castro C
BMC Cancer. 2022; 22(1):769.
PMID: 35840933
PMC: 9284867.
DOI: 10.1186/s12885-022-09851-3.
Adherence to Newly Implemented Tamoxifen Therapy for Breast Cancer Patients in Rural Western Ethiopia.
Reibold C, Tariku W, Eber-Schulz P, Getachew S, Addisie A, Unverzagt S
Breast Care (Basel). 2021; 16(5):484-490.
PMID: 34720808
PMC: 8543345.
DOI: 10.1159/000512840.
Assessing Predictors of Tamoxifen Nonadherence in Patients with Early Breast Cancer.
Montagna E, Zagami P, Masiero M, Mazzocco K, Pravettoni G, Munzone E
Patient Prefer Adherence. 2021; 15:2051-2061.
PMID: 34552323
PMC: 8450184.
DOI: 10.2147/PPA.S285768.
Treatment Adherence in Patients with Lung Cancer from Prospects of Patients and Physicians.
Souliotis K, Peppou L, Economou M, Marioli A, Nikolaidi S, Saridi M
Asian Pac J Cancer Prev. 2021; 22(6):1891-1898.
PMID: 34181348
PMC: 8418830.
DOI: 10.31557/APJCP.2021.22.6.1891.
Adjuvant endocrine therapy for premenopausal women with breast cancer: Patient adherence and physician prescribing practices in Mexico.
Villarreal-Garza C, Mesa-Chavez F, Ferrigno A, De la Garza-Ramos C, Fonseca A, Villanueva-Tamez K
Breast. 2021; 59:8-15.
PMID: 34116366
PMC: 8192863.
DOI: 10.1016/j.breast.2021.05.013.
Adherence to Adjuvant Tamoxifen in Mexican Young Women with Breast Cancer.
Martinez-Cannon B, Castro-Sanchez A, Barragan-Carrillo R, de la Rosa Pacheco S, Platas A, Fonseca A
Patient Prefer Adherence. 2021; 15:1039-1049.
PMID: 34040357
PMC: 8141391.
DOI: 10.2147/PPA.S296747.
Potentially Modifiable Factors Associated with Adherence to Adjuvant Endocrine Therapy among Breast Cancer Survivors: A Systematic Review.
Toivonen K, Williamson T, Carlson L, Walker L, Campbell T
Cancers (Basel). 2021; 13(1).
PMID: 33561076
PMC: 7794693.
DOI: 10.3390/cancers13010107.
Beliefs about medicines and adherence in women with breast cancer on adjuvant endocrine therapy.
Tan E, Wong A, Tan C, Wong P, Tan S, Ang L
J Health Psychol. 2021; 27(5):1111-1124.
PMID: 33550864
PMC: 8978467.
DOI: 10.1177/1359105321990776.
Simulation-Based Assessment of the Impact of Non-Adherence on Endoxifen Target Attainment in Different Tamoxifen Dosing Strategies.
Mueller-Schoell A, Klopp-Schulze L, Michelet R, van Dyk M, Murdter T, Schwab M
Pharmaceuticals (Basel). 2021; 14(2).
PMID: 33546125
PMC: 7913149.
DOI: 10.3390/ph14020115.
Early Discontinuation of Endocrine Therapy and Recurrence of Breast Cancer among Premenopausal Women.
Collin L, Cronin-Fenton D, Ahern T, Goodman M, McCullough L, Waller L
Clin Cancer Res. 2020; 27(5):1421-1428.
PMID: 33334905
PMC: 7925421.
DOI: 10.1158/1078-0432.CCR-20-3974.